Add BrightSurf on Google Email

Science News Archive July 2002 - Page 6


Page 6 of 7

Breakthrough in hormonal breast cancer therapy

Anastrozole, an aromatase inhibitor, has been shown to be more effective than tamoxifen in reducing the risk of breast cancer recurrence, hot flushes, and thromboembolic events. The treatment also reduces the incidence of endometrial abnormalities and vaginal bleeding, providing a significant benefit for postmenopausal women with early...

Gene profiles predict survival

A study identified three gene expression patterns correlated with survival after chemotherapy, which outperformed the International Prognostic Index. The patterns revealed aspects of tumor biology affecting treatment response, including immune system involvement and tumor cell division.

Breakthrough made in electronics technology

Researchers at Oregon State University have made a breakthrough in creating crystalline thin films at lower temperatures without the need for vacuum conditions. This advance could enable the mass production of electronic devices on plastics and facilitate cheaper production of some products.

SourceOregon State University·JournalScience·DateJul 4, 2002

Seven of ten cured of rectal cancer

The Norwegian Cancer Society's project has made significant strides in improving rectal cancer treatment, resulting in a 30% increase in five-year post-operative survival rates since 1999. The project aims to raise quality at hospitals whose results are still not good enough by improving surgery techniques and patient examination prior...

Grant to boost math scholars

The University of California, Davis, has received a $1.9 million grant to support math graduate students' career development. The VIGRE program will provide fellowships and stipends for undergraduate and graduate students, as well as postdoctoral researchers, to help them secure jobs in the software and computer industries.

Sex-specific genes for depression

A study published in Molecular Psychiatry found that specific genetic markers on chromosome 2 are associated with severe depression in women, but not in men. This discovery suggests important differences in the molecular basis of clinical depression between sexes, which may contribute to varying treatment responses and symptoms.

SourceMolecular Psychiatry·JournalMolecular Psychiatry·DateJul 1, 2002